Company Profile

Electronic BioSciences LLC (AKA: Electronic Bio Sciences LLC~Electronic BioSciences Inc)
Profile last edited on: 7/17/2018      CAGE: 3ENS0      UEI: FLHHE89XH2H5

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2002
First Award
2007
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5754 Pacific Center Boulevard Suite 204
San Diego, CA 92121
   (858) 412-1704
   ahibbs@electronicbio.com
   www.electronicbio.com
Location: Multiple
Congr. District: 52
County: San Diego

Public Profile

Electronic BioSciences LLC, alongside its sister company, Quasar (another SBIR awardee) develops state-of-the-art instrumentation for research and sensing applications. The firm’s technology is centered on the measurement of electrical current with exceptionally low noise electronics in order to produce sensitive systems for nanopore and ion channel measurements, with potential applications in DNA sequencing,ion channel characterization, and chemical sensing. The focus of this work is to take cell potential measurements without breaching the cell membrane or otherwise harming the cell. This innovation would allow long-term measurements of intact, living cells, a concept with applications ranging through many fields

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $2,000,000
Project Title: Nanoscale Tools for Inosine Sequencing
2022 1 NIH $400,000
Project Title: Exonuclease Based Microsatellite Sequencing
2022 1 NIH $393,972
Project Title: Two readers for RNA
2022 1 NIH $394,141
Project Title: Dual Reader Protein Sequencing
2022 1 NIH $400,000
Project Title: Comprehensive Botulinum Characterization via the Bilayer Nanowell Integrated Assay

Key People / Management

  Geoffrey Barrall -- President

  Eric Duff -- Vice President, Business Development

  Eric Ervin -- Vice President, Research & Development,

  Sean German

  Anna Schibel

Company News

There are no news available.